Cargando…

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA

This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharrock, Katherine C., Noori, Teymur, Axelsson, Maria, Buti, Maria, Diaz, Asuncion, Fursa, Olga, Hendrickx, Greet, James, Cary, Klavs, Irena, Korenjak, Marko, Maticic, Mojca, Mozalevskis, Antons, Peters, Lars, Rigoni, Rafaela, Rosinska, Magdalena, Ruutel, Kristi, Schatz, Eberhard, Seyler, Thomas, Veldhuijzen, Irene, Duffell, Erika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022013/ https://www.ncbi.nlm.nih.gov/pubmed/36962761 http://dx.doi.org/10.1371/journal.pgph.0000841

Ejemplares similares

Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2023)

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2020)

Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis
por: Nakitanda, Aya Olivia, et al.
Publicado: (2021)

Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2023)

Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries
por: Ahmad, Amena A., et al.
Publicado: (2018)

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
por: Falla, A. M., et al.
Publicado: (2018)

Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021
por: Singh, Jasleen, et al.
Publicado: (2022)

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions
por: Duffell, Erika F, et al.
Publicado: (2017)

Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
por: Falla, Abby May, et al.
Publicado: (2018)

The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
por: Myran, Daniel T, et al.
Publicado: (2018)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
por: Greenaway, Christina, et al.
Publicado: (2018)

Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
por: Mason, Lauren MK, et al.
Publicado: (2019)

Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review
por: Mason, Lauren M. K., et al.
Publicado: (2019)

Screening for Infectious Diseases among Newly Arrived Migrants in EU/EEA Countries—Varying Practices but Consensus on the Utility of Screening
por: Kärki, Tommi, et al.
Publicado: (2014)

Late presentation of chronic viral hepatitis for medical care: a consensus definition
por: Mauss, Stefan, et al.
Publicado: (2017)

Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
por: Vanhamel, Jef, et al.
Publicado: (2023)

Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
por: HOFSTRAAT, S. H. I., et al.
Publicado: (2017)

Accessibility and Acceptability of Infectious Disease Interventions Among Migrants in the EU/EEA: A CERQual Systematic Review
por: Driedger, Matt, et al.
Publicado: (2018)

Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA
por: Deblonde, Jessika, et al.
Publicado: (2015)

The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review
por: Pottie, Kevin, et al.
Publicado: (2018)

Viral hepatitis micro-elimination: models of care and barriers to implementation in 5 EU/EEA prisons
por: Seyler, T, et al.
Publicado: (2022)

Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C
por: Duffell, Erika, et al.
Publicado: (2021)

HIV diagnoses among people born in Ukraine reported by EU/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning
por: Reyes-Urueña, Juliana, et al.
Publicado: (2023)

Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020
por: Margineanu, Ioana, et al.
Publicado: (2022)

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review
por: Greenaway, Christina, et al.
Publicado: (2018)

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review
por: Greenaway, Christina, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020
por: Simões, Daniel, et al.
Publicado: (2020)

Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review
por: Agbata, Eric N., et al.
Publicado: (2018)

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
por: Maticic, M., et al.
Publicado: (2020)

Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries
por: Maticic, Mojca, et al.
Publicado: (2014)

Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries
por: Maticic, Mojca, et al.
Publicado: (2019)

A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia
por: Maticic, Mojca
Publicado: (2014)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)
por: Lazarus, Jeffrey V., et al.
Publicado: (2016)

High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

Monoubiquitination of EEA1 regulates endosome fusion and trafficking
por: Ramanathan, Harish N, et al.
Publicado: (2013)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

Hep‐CORE: a cross‐sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017
por: Lazarus, Jeffrey V, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cjbn15222tu1232lm1bvai8irj